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Abstract
Demographic and clinical factors may influence assessment of autism symptoms. This study 
evaluated these correlates and also examined whether social communication and interaction and 
restricted/repetitive behavior provided unique prediction of autism spectrum disorder diagnosis. 
We analyzed data from 7352 siblings included in the Interactive Autism Network registry. Social 
communication and interaction and restricted/repetitive behavior symptoms were obtained using 
caregiver-reports on the Social Responsiveness Scale. Demographic and clinical correlates were 
covariates in regression models predicting social communication and interaction and restricted/
repetitive behavior symptoms. Logistic regression and receiver operating characteristic curve 
analyses evaluated the incremental validity of social communication and interaction and restricted/
repetitive behavior domains over and above global autism symptoms. Autism spectrum disorder 
diagnosis was the strongest correlate of caregiver-reported social communication and interaction 
and restricted/repetitive behavior symptoms. The presence of comorbid diagnoses also increased 
symptom levels. Social communication and interaction and restricted/repetitive behavior 
symptoms provided significant, but modest, incremental validity in predicting diagnosis beyond 
global autism symptoms. These findings suggest that autism spectrum disorder diagnosis is by far 
the largest determinant of quantitatively measured autism symptoms. Externalizing (attention 
deficit hyperactivity disorder) and internalizing (anxiety) behavior, low cognitive ability, and 
demographic factors may confound caregiver-report of autism symptoms, potentially necessitating 
a continuous norming approach to the revision of symptom measures. Social communication and 
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interaction and restricted/repetitive behavior symptoms may provide incremental validity in the 
diagnosis of autism spectrum disorder.
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Introduction
Autism symptoms vary widely both across individuals meeting categorical diagnosis and the 
remaining population (Constantino and Todd, 2003, 2005; Piven et al., 1997). Accurately 
quantifying autism symptom levels is crucial for advancing assessment, autism spectrum 
disorder (ASD) diagnosis, and research. Unfortunately, there is limited consensus on how 
best to measure autism symptoms, with several different approaches and instruments 
available for clinical and research settings (Lord et al., 2002; Mayes et al., 2009). Caregiver-
report remains an important part of most assessment strategies (Mildenberger et al., 2001; 
Risi et al., 2006). This is driven, in part, by difficulties with observing the full assortment 
and range of autism symptoms in an office visit. For example, qualitative difficulties in 
reciprocal interaction with peers are often determined through caregiver-report rather than 
direct observation. Other symptoms can be inconsistent over time and situation (e.g. 
difficulties with transitions/schedule change, hand flapping when very excited), and 
therefore, may not be observed in a brief encounter. Additionally, questions remain 
concerning how to optimally quantify caregiver symptom ratings. These questions include, 
but are not limited to, whether to adjust symptom reports for relevant demographic and 
clinical factors and whether to evaluate specific symptom domains or global symptom 
severity (Constantino and Gruber, 2005). This study examined these issues by analyzing the 
demographic (age, sex, race/ethnicity, and birth order) and clinical (attention deficit 
hyperactivity disorder (ADHD), any anxiety disorder, and intellectual disability) correlates 
of caregiver-reported autism symptoms and the relationship between symptoms and ASD 
diagnosis.
Several motivations exist for evaluating the correlates of autism symptoms. An important 
theoretical motivation is to determine whether autism symptom domains are truly distinct. If 
distinct patterns of correlates across symptom domains are identified, this may imply the 
need for separate consideration of these domains rather than only global symptom severity. 
Latent variable modeling studies have identified two core symptom domains related to 
social communication and interaction (SCI) and restricted/repetitive behavior (RRB) 
(Frazier et al., 2008, 2012; Snow et al., 2009). Other minor age- or measure-specific 
domains, such as imagination/play, have also been identified but are poorly replicated 
(Frazier et al., 2008). Earlier studies suggested a single global autism severity factor, often 
strongly associated with social communication behavior (Constantino et al., 2004). These 
studies, however, included fewer RRB symptoms or mixed autism symptoms with adaptive 
behavior (Szatmari et al., 2002), thereby pushing findings toward a single factor. 
Furthermore, proposed Diagnostic and Statistical Manual of Mental Disorders (5th ed.; 
DSM-5) criteria contain separate SCI and RRB symptom criteria (American Psychiatric 
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Association, 2011), consistent with the notion that these are distinct, but correlated, 
domains. This study evaluates the issue of domain-specific versus global symptom severity 
by separately examining demographic and clinical correlates of SCI and RRB symptom 
ratings and by assessing whether distinct domains yield incremental validity over global 
autism severity in the prediction of ASD diagnosis.
A practical reason for examining demographic and clinical correlates is that they may be 
important factors to consider when developing or revising measures. Age, sex, cognitive 
functioning, and comorbid behavior problems have all been found to influence autism 
symptom reports (Hus et al., 2013; Mayes and Calhoun, 2010), although the specific 
patterns have been sample- and measure-dependent. For example, results from initial studies 
of the Social Responsiveness Scale (SRS) suggested that it may be relatively independent of 
age and intelligence quotient (IQ), but not sex (Constantino and Gruber, 2005), with males 
showing higher symptom levels. Individuals with comorbid psychopathology have also been 
found to show higher symptom levels (Hus et al., 2013). The SRS contains items beyond 
social behavior, including items tapping RRB content. This provided an opportunity to 
separately evaluate the effects of demographic and clinical factors on SCI and RRB 
domains. Furthermore, this study extends recent work examining both ASD-affected 
individuals and their siblings (Hus et al., 2013) by evaluating the influence of demographic 
and clinical factors before and after accounting for ASD diagnosis. Some factors, 
particularly internalizing and externalizing behavior problems, may be confounded with 
ASD diagnosis. If these factors are significant after accounting for ASD diagnosis, 
adjustment for these factors—either by direct adjustment or through the creation of separate 
norms—may be needed to enhance the specificity of autism symptom measurement.
This study
The first aim of this study was to examine demographic and clinical correlates of SCI and 
RRB symptoms before and after accounting for ASD diagnosis. Evaluating the influence of 
demographic and clinical correlates after accounting for ASD diagnosis is crucial because it 
may be that the relationship between these factors and autism symptoms is largely driven by 
the presence of categorical ASD. In other words, ASD may “travel with” or induce a range 
of disability. If true, controlling for these factors would actually remove variance in the 
measure associated with autism phenotype—an undesirable effect for a measure of autism 
symptoms. Thus, the chosen analytic approach represents the first comprehensive attempt to 
apportion overlap between categorical ASD and other factors into (a) overlap that is a result 
of the presence versus absence of ASD diagnosis and (b) extraneous influences of unrelated 
psychopathological traits on symptom measurement.
Not surprisingly, ASD diagnosis was expected to be the primary driver of SCI and RRB 
symptoms. However, we also hypothesized that age, sex, comorbid ADHD symptoms, 
anxiety disorder diagnosis, and the presence of intellectual disability would be significant 
predictors of SCI and RRB symptoms, even after accounting for ASD diagnosis. The second 
aim of this study was to determine whether caregiver-reported SCI and RRB symptoms, 
considered separately, provided incremental validity in the prediction of ASD diagnosis. 
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Caregiver-reported SCI and RRB symptoms were expected to make significant unique 
contributions to the prediction of clinical ASD diagnosis beyond global symptom severity.
Method
Participants
Data were obtained from the Interactive Autism Network (IAN; www.ianproject.org), an 
internet-based registry for families with one or more ASD-affected children (IAN Data 
Export ID: IAN_DATA_2010-07-06). Families were eligible for enrollment in IAN if the 
parent or legal guardian who provided information was English speaking, the family lived in 
the United States, and their child was diagnosed with an ASD by a professional. To be 
included in this study, caregivers must have reported ASD symptom data for at least one 
ASD-affected child. A subset of IAN caregivers (usually the mother) completed the SRS, as 
this measure was added to the database approximately 9 months after the initial launch of 
IAN. The present analyses are based on the SRS subset of IAN, which includes all registered 
families for whom at least one child (ASD-affected or non-ASD sibling) had completed SRS 
data.
The SRS subsample of IAN has previously been shown to be fairly representative of the 
larger IAN registry (Kalb et al., 2010). Relative to the larger IAN registry, the SRS 
subsample is slightly older, due to the fact that the instrument is completed only for 
individuals aged 4 and older, and has a higher proportion of White/non-Hispanic 
individuals. Additionally, the SRS sample includes fewer nonverbal individuals, as some 
SRS items are geared toward verbal individuals. Caregivers tend to leave these items 
incomplete or simply do not complete the instrument. Previous examinations of these 
subsample differences indicated that the magnitude of the effects ranged from very small to 
small (all standardized mean differences < 0.20) (Frazier et al., 2012). IAN—while an 
internet registry—is fairly representative of the larger population of US families affected by 
ASD, with the primary exception of over-sampling non-Hispanic Whites and higher 
socioeconomic status (SES) demographics.
Procedures
Informed consent was obtained from parents/guardians for all participants prior to entry into 
the IAN data collection. The procedures of IAN and this study were reviewed and approved 
by the institutional review boards of Kennedy Krieger Institute and Cleveland Clinic, 
respectively. Demographics, comorbid clinical symptoms and diagnoses, and autism 
symptoms were provided by caregivers as part of participation in IAN.
ASD diagnosis—The vast majority of clinical ASD diagnoses (93%) were provided by a 
doctoral-level professional or team. A substantial proportion of youth (74.9%) were 
diagnosed using the Autism Diagnostic Interview–Revised, the Autism Diagnostic 
Observation Schedule, or both. Of these, 98.7% scored in the ASD-affected range for one or 
both instruments. A recent study of youth from the IAN registry by Lee et al. (2010) 
supported the validity of clinical ASD diagnoses. In this study, randomly selected verbal 
youth with a score >12 on the Social Communication Questionnaire were evaluated using 
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the Autism Diagnostic Interview–Revised and by an expert clinician’s observation. All but a 
handful of youth (2%) were confirmed to have a Diagnostic and Statistical Manual of 
Mental Disorders (4th ed., text revision; DSM-IV-TR) clinical diagnosis of ASD (autistic 
disorder, pervasive developmental disorder–not otherwise specified (PDD-NOS), or 
Asperger’s disorder). Thus, IAN caregiver-reported clinical ASD diagnoses serve as an 
excellent proxy for diagnoses based on semistructured clinical interview and/or observation. 
ASD diagnosis was coded by collapsing all DSM-IV-TR autism spectrum diagnoses into a 
single category (ASD vs non-ASD) following Centers for Disease Control and Prevention 
(CDC, 2012) epidemiologic surveillance protocols.
Demographic and clinical factors were also reported for siblings without a clinical ASD 
diagnosis. Many of these siblings have caregiver-reported psychiatric or developmental 
diagnoses (Constantino et al., 2010). For this reason, we refer to these siblings as non-ASD 
siblings.
Measures
SRS—Autism symptom data were obtained using the SRS (Constantino and Gruber, 2005). 
The SRS is a 65-item, ordinally scaled (1 = “not true” to 4 = “almost always true”) 
quantitative assessment of the severity of autism traits. It is one of the most frequently used 
quantitative measures of autism symptoms, showing strong measurement properties in 
healthy and autism-affected samples, is one of the few measures with separate norms by sex, 
and is frequently incorporated in research to evaluate global autism trait severity 
(Constantino and Gruber, 2005). The SRS total raw score is typically reported in research, 
and the sexadjusted T-score is available for clinical interpretation. In addition to the total 
score, SRS items are divided conceptually into five subscales: Social Cognition, Social 
Awareness, Social Communication, Social Motivation, and Autistic Mannerisms. The first 
four subscales tap SCI symptoms, while the last subscale includes symptoms consistent with 
the RRB domain. For this study, raw scores for SRS social subscales were summed to create 
an aggregate score for the SCI symptom domain. The raw score for the subscale autistic 
mannerisms was used to evaluate the RRB domain. This scoring was based on a recent 
latent variable modeling study of the SRS (Frazier et al., 2012). Internal consistency 
reliability was excellent for the SRS total raw score (α = 0.99), SCI domain (α = 0.98), and 
RRB domain (α = 0.94).
Demographic and clinical covariates—Demographics included age, sex, race/
ethnicity (coded White non-Hispanic, other race/ethnicity), and birth order. Clinical 
covariates included caregiver-reported clinical diagnoses (any ADHD, anxiety disorder, or 
intellectual disability). These covariates were derived from specific questions included in the 
IAN questionnaire completed by caregivers. Questions included the following: “Has (child 
name) ever been diagnosed with or received treatment for ADHD or attention deficit 
disorder (ADD)?” “Has (child name) ever been diagnosed with or received treatment for an 
anxiety disorder?” and “Has (child name) ever been diagnosed with mental retardation?” 
Caregivers responded “yes” or “no” to each question. In the case of ADHD, a comorbid 
diagnosis is typically not permitted by DSM-IV-TR but is often given in practice by 
clinicians who wish to describe significant comorbid ADHD symptoms. For ease of 
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communication and to maintain consistency with other caregiver-reported diagnoses, we 
refer to this ADHD symptom pattern as a dichotomously coded comorbid ADHD diagnosis 
(ADHD vs non-ADHD). Caregiver-reports of any anxiety disorder or intellectual disability 
diagnosis were also coded as single categories (anxiety disorder vs no anxiety or intellectual 
disability vs no intellectual disability). These three caregiver-reported clinical diagnoses 
should be viewed only as proxies for actual clinical diagnoses or symptom patterns but serve 
the useful purpose of estimating the effects of externalizing (ADHD) and internalizing 
(anxiety) behavior or lower cognitive level (intellectual disability) on autism symptoms. The 
estimates obtained for these correlates should be viewed as lower bound estimates of the 
true relationship with autism symptoms because caregiver-reported clinical diagnoses may 
be less reliable than those based on semistructured interviews or observations.
Analytic plan
Independent sample t-tests and Pearson’s chi-square were used to compare sample 
characteristics across ASD-affected and non-ASD siblings. Nonparametric equivalents 
produced the same pattern of results, and therefore, parametric statistics are reported to 
facilitate effect size calculation for future meta-analyses.
Missing data were anticipated for several of the variables included in this study. For this 
reason, missing data analyses focused on the pattern and quantity of missing data. The 
empirically recommended approach of generating multiple imputations was used (Schafer 
and Graham, 2002). To account for missing data, three imputed data files were created, and 
analyses were computed on these files and the original data set.
Correlates of autism symptom domains (Aim 1)—To examine aim 1, four mixed-
effects regression models were estimated. The first two models included age, sex, race/
ethnicity, birth order, any ADHD diagnosis, any anxiety disorder diagnosis, and a diagnosis 
of intellectual disability. SCI and RRB symptoms served as dependent variables in separate 
analyses. The second two models were similar to above except that clinical ASD diagnosis 
(ASD vs non-ASD) was added as a covariate. Follow-up regression analyses examined 
interactions between clinical ASD diagnosis and covariates to examine whether the 
covariate effects differed across ASD and non-ASD groups.
Mixed-effects regressions modeled individual- and family-level variables while accounting 
for the nested nature of the sample, with many families contributing multiple siblings. 
Model fit was considered by iteratively examining alternative covariance structures (Bryk 
and Raudenbush, 1992; Kreft, 1995; Peugh and Enders, 2005). Final models were estimated 
using restricted maximum-likelihood estimation and were presented based on fixed effects 
and scaled identity covariance structures, which fit comparably and yielded a highly similar 
pattern of results to other more complex structures (autoregressive, diagonal, etc.). 
Significant covariates are described as predictors of autism symptoms only in the statistical 
sense because all information was cross-sectional. Follow-up regression analyses examined 
whether significant covariate main effects were modified by ASD diagnosis. In these post 
hoc analyses, only the individual covariate, ASD diagnosis, and their interaction were 
included.
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Incremental validity of SCI and RRB symptoms (Aim 2)—To examine aim 2, we 
first computed receiver operating characteristic curves for caregiver-reported SRS total 
scores and SCI and RRB symptoms. Clinical ASD diagnosis was the state (outcome) 
variable for each curve. Predictive efficiency was determined using areas under the curve 
(AUCs). Second, we computed a hierarchical logistic regression model with SRS total 
scores entered in step 1 and either SCI or RRB symptoms entered in step 2. This evaluated 
whether specific domains may improve prediction beyond global autism symptom severity. 
Third, we computed two hierarchical logistic regression models with SCI and RRB 
symptoms alternating between step 1 and step 2. These models directly test whether separate 
autism symptom domains provide incremental validity in the prediction of ASD diagnosis. It 
is important to note that these analyses do not speak to the absolute efficiency of SRS-
derived measures in predicting ASD diagnosis because caregivers provided symptoms with 
knowledge of the clinical diagnosis. Instead, these analyses are meant to examine the 
relative and incremental validity of SRS-derived measures.
Sensitivity analyses—Follow-up sensitivity analyses examined whether the pattern of 
results differed when using empirically derived diagnostic classifications (Frazier et al., 
2012) as an alternative diagnostic criterion to caregiver-reported ASD diagnosis. These 
empirically derived diagnostic classifications were computed based on the results of factor 
mixture model analyses of SRS item packets in Mplus. Factor mixture models examine 
whether both latent categories and latent dimensions are needed to most accurately 
characterize covariances between symptoms. Empirical classifications are helpful for 
evaluating whether results from primary analyses were due to caregiver knowledge of the 
ASD diagnosis when reporting symptoms.
All analyses were computed in IBM SPSS version 19. Statistical significance was 
determined using p < 0.001. This conservative alpha level was used to reduce potential for 
Type 1 error because the magnitude of effects for significant predictors is most relevant. 
Effect magnitude was quantified for all variables using the familiar correlation (r) metric. To 
quantify magnitude for each covariate, F-statistics were converted to r. These r values 
represent effect magnitude of each variable after accounting for all other variables in the 
model, analogous to partial r coefficients. For this study, partial correlation (rab.c) values 
less than 0.04 were described as very small, 0.04–0.10 small, 0.10–0.30 small to medium, 
and 0.30–0.50 medium to large, although it should be recognized that the latter three 




Table 1 presents demographic and clinical characteristics for ASD-affected and non-ASD 
siblings. ASD-affected siblings were younger and more likely to be early in the birth order. 
These differences may reflect the decreased likelihood of having additional children after 
having a child with ASD (stoppage). ASD-affected siblings were also more likely to be 
male, reflecting the male predominance in ASD; more likely to have a comorbid ADHD 
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diagnosis, an anxiety disorder, or intellectual disability diagnosis; and had substantially 
higher SRS scores. Intellectual disability is clearly underreported in this sample relative to 
clinical expectations in individuals with ASD, reinforcing the notion that caregiver-reports 
of comorbidities are only proxies for actual clinical observations.
Inspection of the means and standard deviations for SRS-derived scores reveals a positively 
skewed but wide distribution of autism symptoms in non-ASD siblings with central 
tendency only slightly below the population normative mean (T = 46.6 vs T = 50). ASD-
affected siblings also showed a wide but elevated distribution of symptoms. These wide 
symptom ranges are ideal for examining the effects of demographic or clinical correlates on 
autism symptom domains.
Missing data
Small proportions of data were missing for four variables: comorbid ADHD diagnosis 
(2.3%), any anxiety disorder (2.3%), intellectual disability (2.4%), and birth order (2.7%). 
This resulted in a very small percent of overall missing data across the 11 primary variables 
included in the analyses (0.9%). Correlations between missingness and imputed values were 
very small and nonsignificant (all pooled r < 0.03, p > 0.05), indicating that data 
approximate the missing at random assumption. Analyses across three imputed data sets 
were highly similar to each other and to analyses of the original data—there were no 
changes in the significance of parameter estimates across the original or imputed data, and 
all parameter estimates were stable (within ±0.02). These results suggest that the effects of 
missing data are not likely to be substantial. For simplicity, results are presented for the 
original nonimputed data.
Power
Power to detect significant covariate effects in aim 1 was computed assuming N = 7352, 
alpha level of p < 0.001 (two-tailed), and a range of covariate effects—partial correlations 
rab.c = 0.03–0.10. Power to detect significant covariate effects was very good (Power > 0.84) 
for effect sizes rab.c = 0.05 and larger. Power to detect very small covariate effects of rab.c = 
0.04 was modest (Power = 0.55). Low power for very small covariate effects was less 
problematic because these effects may not be of conceptual or practical significance. Power 
for aim 2 was expected to be comparable to aim 1 given the similar nature of models.
Correlates of SCI and RRB symptoms
Without ASD diagnosis—Initial mixed-effects regression analyses examined the 
influence of demographic and clinical correlates on SCI and RRB without including ASD 
diagnosis. Age, sex, comorbid ADHD diagnosis, any anxiety disorder diagnosis, and 
intellectual disability were significant unique predictors of SCI and RRB scores (smallest 
F(1, 7134) = 252.17, p < 0.001). Birth order was a marginally significant predictor of RRB 
scores (F(1, 7134) = 10.44, p = 0.001) but did not significantly predict SCI scores (F(1, 
7134) = 2.16, p = 0.142). Race/ethnicity was not a significant predictor of SCI or RRB 
scores (largest F(1, 7134) = 3.14, p = 0.076).
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With ASD diagnosis—The next set of mixed-effects regression analyses examined 
correlates after including ASD diagnosis as an additional covariate. ASD diagnosis was the 
largest predictor of both SCI (total R2 = 0.69, p < 0.00001; ASD diagnosis unique predictive 
component R2 = 0.45; F(1, 7133) = 10074.95, p < 0.001) and RRB scores (total R2 = 0.66, p 
< 0.00001; ASD diagnosis unique predictive component R2 = 0.41; F(1, 7133) = 8780.14, p 
< 0.001), with very large effect sizes for both domains (SCI: r = 0.67; RRB: r = 0.64). After 
including ASD diagnosis, demographic and other clinical factors tended to show much 
smaller influences on SCI (unique R2 = 0.02) and RRB symptoms (unique R2 = 0.02). The 
largest remaining effects for both domains were observed for any ADHD diagnosis, any 
anxiety disorder diagnosis, or intellectual disability (r = 0.11–0.13; all p < 0.001; SCI largest 
F(1, 7133) = 114.40, p < 0.001 was for intellectual disability; RRB largest F(1, 7133) = 
106.96, p < 0.001 was for any anxiety disorder diagnosis). Age and sex showed slightly 
different patterns across SCI and RRB symptoms. For SCI, but not RRB, age trended toward 
statistical significance (r = 0.04, F(1, 7133) = 9.91, p = 0.002). For RRB, but not SCI, sex 
was a significant unique predictor (r = 0.06, F(1, 7133) = 32.49, p < 0.001). Race/ethnicity 
was not a significant predictor of SCI or RRB after considering ASD diagnosis (largest F(1, 
7133) = 3.00, p = 0.083). Intercepts and regression parameters are presented in 
Supplementary Table 1.
Effect magnitude—Figures 1 and 2 present the magnitude (r) of unique predictive effects 
on SCI and RRB scores, with and without simultaneously covarying for ASD diagnosis. The 
largest effects were seen for age, sex, any ADHD diagnosis, any anxiety disorder, and 
intellectual disability before and after covarying for ASD diagnosis. Sex showed a very 
large relationship with SCI and RRB scores before accounting for ASD diagnosis, but this 
relationship was considerably smaller after including ASD diagnosis. A dramatic decrease is 
easily observed in the magnitude of most covariate effects after including ASD diagnosis.
Interactions with ASD diagnosis—Follow-up regression analyses examined 
interactions between demographic/clinical covariates and ASD diagnosis. Table 2 presents 
SCI and RRB raw scores at representative levels of each covariate, separately for ASD and 
non-ASD youth. SCI scores decreased across age groups in both ASD-affected and non- 
ASD youth (interaction F(4, 7126) = 0.47, p = 0.759). RRB scores remained fairly stable 
across age groups in both ASD-affected and non-ASD youth (interaction F(4, 7126) = 0.57, 
p = 0.688). The presence of caregiver-reported ADHD, anxiety, and intellectual disability 
resulted in substantial increases in the level and variability of SCI and RRB symptoms in the 
non-ASD youth; increases were smaller but still significant and sizeable in ASD-affected 
youth (smallest interaction F(1, 7132) = 12.13, p < 0.001 for intellectual disability with SCI 
scores). The only exception was a nonsignificant trend for the interaction of ASD diagnosis 
and intellectual disability on RRB scores (F(1, 7132) = 2.76, p = 0.097). No significant 
interactions were observed for sex, race/ethnicity, or birth order (largest F(2, 7130) = 4.88, p 
= 0.008 for birth order with SCI scores). Intercepts and regression parameters are presented 
in Supplementary Table 1.
Frazier et al. Page 9













Incremental prediction of ASD diagnosis
Figure 3 presents receiver operating characteristic curves for SRS total, SCI, and RRB 
scores in predicting clinical ASD diagnosis. AUC values were quite strong, all falling above 
0.95, which is considered very strong discrimination of ASD versus non-ASD siblings. The 
AUCs were also highly similar for SRS total, SCI, and RRB scores (all AUC 95% CIs 
overlap; SRS total raw score = 0.969, 95% confidence interval (CI) = 0.964–0.973; SCI raw 
score = 0.966, 95% CI = 0.961–0.970; RRB raw score = 0.967, 95% CI = 0.963–0.971). 
Correlations between SCI and RRB scores were generally high but slightly lower in ASD-
affected siblings relative to non-ASD siblings (ASD: r = 0.79, non-ASD: r = 0.86). These 
high but imperfect relationships indicate that the SCI and RRB domains may show 
incremental validity in predicting ASD diagnosis. Consistent with this hypothesis, SCI and 
RRB scores provided small, but highly significant, improvements in the prediction of ASD 
diagnosis beyond SRS total scores (Step 1—SRS total scores entered: R = 0.902, R2 = 0.814, 
Wald χ2(1) = 6733.70, p < 0.0001; Step 2—SCI/RRB scores added: smallest ΔR = 0.071, 
ΔR2 = 0.005, Wald χ2(1) = 68.15, p < 0.0001). Additionally, SCI and RRB scores displayed 
incremental validity when considered iteratively in the prediction of ASD diagnosis 
(smallest ΔR = 0.12, ΔR2 = 0.015, Wald χ2(1) = 206.95, p < 0.0001; final model constant = 
−4.15, standard error (SE) = 0.110; SCI B = 0.052, SE = 0.003; RRB B = 0.183, SE = 
0.013).
Sensitivity analyses
Empirically derived diagnostic classifications (ASD and non-ASD) were highly correlated, 
but not redundant, with caregiver-reported clinical ASD diagnosis (r = 0.90). Using 
empirical classifications did not substantively change the pattern (magnitude or significance) 
of findings. As with caregiver-reported clinical diagnoses, empirical classifications result in 
similar AUC values for SRS total, SCI, and RRB scores (all AUC 95% CIs overlap; SRS 
total raw score = 0.977, 95% CI = 0.974–0.981; SCI raw score = 0.975, 95% CI = 0.972–
0.979; RRB raw score = 0.974, 95% CI = 0.970–0.977). Both SCI and RRB scores provided 
small, but highly significant, improvements in the prediction of empirical classifications 
beyond SRS total scores (smallest ΔR = 0.06, ΔR2 = 0.004, χ2(1) = 53.09, p < 0.0001). 
Additionally, SCI and RRB scores provided incremental validity when considered iteratively 
in the prediction of empirical classifications (smallest ΔR = 0.11, ΔR2 = 0.013, χ2(1) = 
174.98, p < 0.0001).
Discussion
ASD diagnosis was the strongest individual correlate of SCI and RRB symptoms, uniquely 
accounting for the majority of variance in both symptom domains. This observation 
indicates that in this sample, the SRS showed good discrimination between typical and 
pathological levels of SCI and RRB symptoms. Mean scores of ASD and non-ASD youth 
were consistent with mean scores in previous SRS studies (Constantino and Gruber, 2005). 
This implies that caregiver knowledge of ASD diagnosis did not substantially alter the 
spread of scores between ASD and non-ASD siblings and, therefore, may not account for 
the present findings. Additionally, the consistency of findings using clinical ASD diagnoses 
and empirical classifications further confirms previous observations that categorical ASD 
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diagnosis is strongly associated with quantitative autism symptom measurement 
(Constantino et al., 2003a).
The next strongest correlates of SCI and RRB symptoms were the presence of any ADHD, 
anxiety disorder, or intellectual disability. Youth with any of these caregiver-reported 
diagnoses had meaningfully higher SCI (5–12 raw score points higher on average) and RRB 
symptoms (2–3 raw score points higher) after accounting for ASD diagnosis. In particular, 
the presence of ADHD, anxiety, or intellectual disability in non-ASD youth increased SCI 
and RRB symptom ratings. Symptom increases in non-ASD youth increased overlap 
between ASD and non-ASD cases, making discrimination more challenging. At a theoretical 
level, this overlap likely reflects genetic relationships between ASD and other development 
problems (Constantino et al., 2003b; Lichtenstein et al., 2010; Lundstrom et al., 2011). In 
this sense, overlap may be unavoidable, reflecting the true nature of the genetic relationships 
between different forms of developmental psychopathology, rather than a limitation of the 
instrument. At a practical level, overlap raises the problem of clinically discriminating 
categorical ASD from non-ASD. Because internalizing and externalizing behaviors, as well 
as global ability level, may influence caregiver-reports of autism symptoms, clinicians 
collecting parent-report measures in youth with comorbid neuropsychiatric disorders or 
symptom patterns would be wise to consider these influences in their score interpretation. 
Future revisions of the SRS should consider examining these and possibly other factors as 
norms are developed. Identifying and removing items that are most sensitive to comorbid 
symptom patterns and do not represent core ASD symptoms have the potential to 
substantially reduce score overlap. Overlap also suggests the practical implication that 
proposed DSM-5 diagnostic criteria should consider permitting comorbid diagnoses in 
individuals who show high levels of both autism and cooccurring developmental 
psychopathology.
Age, sex, and birth order effects—while weaker and more variable across SCI and RRB 
domains—also influenced symptoms. Younger, male, and later born siblings tended to have 
higher symptom levels. The pattern is consistent with previous longitudinal data suggesting 
improvements in ASD symptoms with development (Charman et al., 2005; Moss et al., 
2008) and literature suggesting higher levels of autism traits in the male population 
(Constantino and Todd, 2003). The observation of later born siblings having greater 
symptoms may reflect greater sensitivity to atypical development in caregivers with larger 
family sizes, where the majority of children do not have ASD. Results for sex were 
consistent with literature suggesting higher levels of autism traits in the male population 
(Constantino and Todd, 2003). Interestingly, there were no sex differences for RRB among 
ASD cases. Previous studies suggest that females with ASD show reduced RRB symptoms 
relative to males with ASD (Lord et al., 1982; Mandy et al., 2012a), although differences 
appear to be less prominent in young children (Carter et al., 2007). The lack of differences 
for RRB in the present sample may be due to under-sampling of high-functioning females 
with ASD rather than true equivalence between sexes (Frazier et al., 2012). Future 
replication studies with careful sampling of high-functioning females are needed to ensure 
the stability and generalizability of age, sex, and birth order effects. If replicated, revisions 
of the SRS would benefit from separate or continuous norming approaches that account for 
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these factors (Hus et al., 2013). These revisions may also consider generating indices that 
specifically evaluate SCI and RRB symptoms and can be linked to proposed DSM-5 criteria.
This study also presented the unique opportunity to examine the impact of clinical and 
demographic factors on autism symptom measurement before and after accounting for 
categorical ASD diagnosis. Recent work by Hus et al. (2013) identified substantial 
influences of behavior problems and cognitive impairment on SRS scores before accounting 
for categorical ASD diagnosis. One interpretation of these relationships is that external 
factors “cause” higher autism symptom levels. The present results suggest an alternative 
explanation—that behavior problems and cognitive disability increase caregiver-reports of 
autism symptoms in unaffected siblings and that the presence of a categorical ASD 
diagnosis induces a range of behavioral disability. The implication is that overlap between 
autism-related traits and other psychopathological traits can be theoretically apportioned into 
(a) overlap that is a result of the presence versus absence of an ASD diagnosis and (b) 
extraneous influences of unrelated psychopathological traits on symptom measurement. 
Practically, this implies that in some instances, controlling for behavioral disability would 
obscure autism symptom measurement, particularly in research attempting to link behavior 
with underlying genetic or neurobiologic variation. In situations where a clinician or 
researcher is interested in discriminating individuals with high autism symptom levels from 
other forms of psychopathology, then it would be reasonable to consider adjustment for 
these other psychopathological constructs.
The SRS has typically been interpreted using a single score reflecting global autism 
symptom/trait severity. Yet, in this study, SCI and RRB symptoms were imperfectly 
correlated (particularly in ASD-affected youth) and had a slightly different pattern of 
relationships with age and sex. Furthermore, SCI and RRB scores produced incremental 
validity over the SRS total raw score in spite of the already strong predictive validity of the 
total score. These findings, coupled with previous studies of autism symptom structure 
(Frazier et al., 2008; Mandy et al., 2012b), provide preliminary validation of proposed 
DSM-5 symptom domains and support separation of SCI and RRB. Future revisions of the 
SRS and other symptom measures—and current use of symptom measures in research—may 
benefit from the development and use of subscales tapping these distinct domains. 
Additional studies with raters blinded to diagnosis are needed to further establish the 
incremental validity of SCI- and RRB-derived indices from the SRS and their 
correspondence to proposed DSM-5 domains. These studies will be helpful for developing 
evidence-based medicine procedures (e.g. cut scores, diagnostic likelihood ratios) for using 
SCI- and RRB-derived measures in screening for ASD.
Limitations and future directions
The primary limitations of this study were simultaneous ascertainment of the SRS and ASD 
diagnoses, reliance on caregiver-reported clinical ASD diagnoses and comorbidities, and use 
of sibling data from an internet-based registry. Simultaneous collection of the SRS and ASD 
diagnoses from caregivers may have exaggerated the validity of the SRS. As a result, the 
effect sizes for ASD diagnosis in predicting SCI and RRB symptoms may be larger than the 
true effect size. Similarly, AUC values for SCI and RRB symptoms may be inflated. 
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However, the results of sensitivity analyses using empirical classifications were highly 
similar and produced comparable effect sizes. This suggests that exaggeration cannot 
completely explain the very large effects observed for ASD diagnosis relative to other 
demographic and clinical factors. Furthermore, the previous validation study of ASD 
diagnoses in IAN (Lee et al., 2010), and the relative similarity between SRS scores in this 
study and in previous SRS validation work (Constantino et al., 2003a; Constantino and 
Gruber, 2005), indicates that the present findings are not substantially misestimated. 
Additional studies with independent diagnoses, although expensive and laborious to collect 
on a large scale, will be needed to confirm the present results.
Caregiver-reports of ADHD, anxiety disorder, or intellectual disability diagnoses are weak 
proxies for diagnoses based on semistructured research interviews. As a result, these effects 
are biased. Specifically, they almost certainly under-estimate the true relationships between 
internalizing and externalizing behavior, cognitive ability, and autism symptoms. Therefore, 
it is possible that these clinical factors may influence autism symptoms beyond the level 
observed in this study. Clearly, direct assessment of clinical diagnoses or the broader 
psychopathology constructs will be crucial for determining the exact magnitude of effects on 
SCI and RRB domains. Regardless, the present results indicate that the effects of these 
clinical correlates are not trivial and likely reduce the purity of caregiver-reports of autism 
symptoms.
The IAN internet registry does not include data from families unaffected by ASD. Saturation 
of ASD-affected cases may have enhanced the effect of ASD diagnosis in predicting SRS-
derived autism symptom domains. However, the opposite is also possible; non-ASD siblings 
may provide a more stringent comparison than healthy individuals from the general 
population. Furthermore, the national scope and large size of the IAN registry make it 
preferable for quantifying the effects of multiple factors on autism symptom reports, 
covering the full range of autism symptom severity.
In spite of these limitations, the present findings indicate that quantitative, caregiver-
reported autism symptoms are heavily influenced by the presence of an ASD diagnosis and, 
therefore, are excellent additions to the screening and assessment of ASD. Careful clinical 
assessments of ASD will benefit from considering the impact of demographic and other 
clinical factors on these caregiver-reports. Clinicians may also consider SCI and RRB 
symptoms separately, as these domains appear to have incremental validity in the prediction 
of ASD over global symptom alone. Future studies are needed to determine whether 
separate symptom domains should be used to track treatment response. Longitudinal studies 
will be valuable for further refining our understanding of demographic and clinical 
influences on SCI and RRB symptoms throughout development.
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Refer to Web version on PubMed Central for supplementary material.
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Magnitude (r) of unique predictive effects for SCI, with and without ASD diagnosis as a 
covariate.
SCI: social communication and interaction; CI: confidence interval; ASD: autism spectrum 
disorder; ADHD: attention deficit hyperactivity disorder. All 95% CIs are <±0.01 (not 
shown).
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Magnitude (r) of unique predictive effects for RRB, with and without ASD diagnosis as a 
covariate.
RRB: restricted/repetitive behavior; CI: confidence interval; ASD: autism spectrum 
disorder; ADHD: attention deficit hyperactivity disorder. All 95% CIs are <±0.01 (not 
shown).
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Receiver operating characteristic curves for SRS total raw, SCI raw, and RRB raw scores 
show close overlap in the prediction of ASD diagnosis.
RRB: restricted/repetitive behavior; SRS: Social Responsiveness Scale; SCI: social 
communication and interaction; ASD: autism spectrum disorder.
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Table 1
Demographic and clinical characteristics of ASD-affected and non-ASD siblings.
Non-ASD ASD t/χ2 (p)
N 2848 4504
Age (SD) 9.5 (4) 8.8 (4) 7.98 (<0.001)
Female (%) 53.1 17.3 1040.55 (<0.001)
Birth order (SD) 1.7 (1) 1.8 (1) 6.17 (<0.001)
White non-Hispanic (%) 86.9 86.2 0.76 (0.384)
Any ADHD (%) 12.3 32.4 373.47 (<0.001)
Any anxiety (%) 5.8 20.8 304.18 (<0.001)
Intellectual disability (%) 0.5 8.8 220.96 (<0.001)
SRS total raw (SD) 24.2 (24) 105.9 (30) 122.67 (<0.001)
SRS total T-score (SD) 46.6 (12) 86.1 (15) 114.80 (<0.001)
SRS: Social Responsiveness Scale; SD: standard deviation; ADHD: attention deficit hyperactivity disorder; ASD: autism spectrum disorder.
SRS total raw score ranges from 0 to 195. Any ADHD, any anxiety disorder, and intellectual disability are caregiver-reported clinical diagnoses.
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Table 2
SCI and RRB raw scores at representative levels of demographic and clinical covariates, separately for ASD 
and non-ASD siblings.
SCI RRB
Non-ASD ASD Non-ASD ASD
M (SD) M (SD) M (SD) M (SD)
Age, years
  4–6 33.03 (32.91) 94.81 (38.21) 6.42 (9.02) 21.86 (10.47)
  7–9 32.67 (29.81) 92.97 (30.38) 6.65 (8.17) 22.33 (8.33)
  10–13 32.04 (28.08) 93.94 (26.98) 6.49 (7.70) 22.48 (7.40)
  13–15 31.68 (26.29) 92.49 (25.25) 6.31 (7.21) 22.25 (6.92)
  16–18 31.18 (24.45) 91.15 (23.24) 5.85 (6.70) 21.73 (6.37)
Sex
  Female 31.28 (36.70) 93.82 (26.80) 6.13 (10.07) 21.56 (7.35)
  Male 33.68 (35.18) 94.13 (42.79) 6.91 (9.65) 22.68 (11.74)
Race/ethnicity
  White/non-Hispanic 32.32 (40.95) 93.85 (40.95) 6.61 (11.23) 22.41 (11.23)
  Other 34.13 (26.34) 92.70 (25.96) 6.94 (7.22) 21.64 (7.12)
Birth order
  1 32.15 (34.09) 91.48 (37.15) 6.47 (9.36) 21.89 (10.20)
  2 32.30 (32.92) 95.09 (31.28) 6.43 (9.03) 22.34 (8.59)
  3+ 34.97 (27.51) 97.53 (26.72) 6.96 (7.55) 22.70 (7.34)
ADHD symptoms
  Not reported 28.13 (42.66) 91.84 (41.08) 5.53 (11.75) 21.62 (11.32)
  Reported 45.83 (25.52) 94.76 (30.85) 9.02 (7.03) 22.60 (8.50)
Anxiety diagnosis
  Not reported 27.94 (41.58) 90.21 (41.01) 5.26 (11.42) 21.14 (11.26)
  Reported 46.52 (23.50) 95.93 (28.17) 9.71 (6.45) 22.95 (7.74)
Intellectual disability
  Not reported 26.24 (33.92) 87.57 (34.13) 4.88 (9.31) 20.56 (9.37)
  Reported 58.49 (22.60) 99.13 (23.09) 10.73 (6.20) 23.70 (6.34)
SCI: social communication and interaction; RRB: restricted/repetitive behavior; SD: standard deviation; ADHD: attention deficit hyperactivity 
disorder; ASD: autism spectrum disorder.
SCI total raw scores range from 0 to 159 and RRB total raw scores range from 0 to 36. Age: 4–6 (n = 2806), 7–9 (n = 1860), 10–12 (n = 1293), 13–
15 (n = 950), 16–18 (n = 443) years; male: n = 5060, Female: n = 2292; White non-Hispanic: n = 6357, other race/ethnicity: n = 995; Birth order: 1 
(n = 3429), 2 (n = 2460), 3+ (n = 1265); ADHD diagnosis: reported (n = 1767), not reported (n = 5417); anxiety diagnosis: reported (n = 1073), not 
reported (n = 6108); intellectual disability: reported (n = 400), not reported (n = 6777).
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